通过使用共价激酶结合元件的双价方法来增强波罗样激酶1波罗盒域结合联体的亲和力
Kohei Tsuji1,2, Hirokazu Tamamura2, Terrence R Burke1
1Chemical Biology Laboratory, Center for Cancer Research, National Cancer Institute, National Institutes of Health Frederick MD 21702 USA burkete@mail.nih.gov.
RSC chemical biology
|August 2, 2024
概括
研究人员开发了强大的双价抑制剂,通过将激酶域抑制剂与波罗盒域绑定剂相结合,准波罗样激酶1 (Plk1). 这些新的基于Wortmannin的配体显示出显著的Plk1亲和力,有助于用于抗癌药物开发的结构研究.
科学领域:
- 生物化学 生物化学
- 分子生物学分子生物学
- 药用化学 医学化学
背景情况:
- 波罗样酶1 (Plk1) 是一个重要的细胞循环调节剂,也是抗癌疗法的有希望的标.
- Plk1包括一个酶域 (KD) 和一个参与基本蛋白质-蛋白质相互作用的波罗盒域 (PBD).
- 之前的研究使用了BI2536和PBD结合的双价策略,以获得高亲缘关系的Plk1抑制剂.
研究的目的:
- 研究使用沃特曼宁作为Plk1 KD结合元件的双价联体的疗效.
- 评估使用基于沃特曼宁的双价抑制剂实现的Plk1亲和力增强.
- 探索这些紧固结合连接体的潜力,用于对全长Plk1.1的结构分析.
主要方法:
- 设计和合成含有Wortmannin和PBD结合部分的双价联体.
- afinity 测量用于量化 Plk1 的结合.
- 与之前开发的基于BI2536的双价抑制剂的结合 afinities 的比较.
主要成果:
- 与沃特曼宁配合的双对应干体显示出显著的Plk1亲和力增强,与BI2536.
- 开发的基于Wortmannin的配体表现出与Plk1.1的紧密结合.
- 亲和力增强表明结构研究的潜力.
结论:
- 基于沃特曼宁的双价联体有效地实现了对Plk1.1的高亲和度抑制.
- 这些连接体代表了未来对Plk1.1的结构研究的宝贵工具.
- 双价方法为开发针对Plk1.1的新型抗癌剂提供了一个有希望的战略.
相关概念视频
Ligand Binding and Linkage
4.8K
Allosteric proteins have more than one ligand binding site; the binding of a ligand to any of these sites influences the binding of ligands to the other sites. When a protein is allosteric, its binding sites are called coupled or linked. In the case of enzymes, the site that binds to the substrate is known as the active site and the other site is known as the regulatory site. When a ligand binds to the regulatory site, this leads to conformational changes in the protein that can influence...
4.8K
Cooperative Allosteric Transitions
7.9K
Cooperative allosteric transitions can occur in multimeric proteins, where each subunit of the protein has its own ligand-binding site. When a ligand binds to any of these subunits, it triggers a conformational change that affects the binding sites in the other subunits; this can change the affinity of the other sites for their respective ligands. The ability of the protein to change the shape of its binding site is attributed to the presence of a mix of flexible and stable segments in the...
7.9K
Ligand Binding Sites
12.8K
Proteins are dynamic macromolecules that carry out a wide variety of essential processes; however, the activities of most proteins depend on their interactions with other molecules or ions, known as ligands.
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
12.8K
Assembly of Signaling Complexes
5.7K
Multiprotein signaling complexes are formed in a dynamic process involving protein-protein interactions at the cytoplasmic domain of transmembrane receptors or enzymatic and non-enzymatic proteins associated with the receptor. These complexes ensure the activation and propagation of intracellular signals that regulate cell functions.
Interaction domains in cell signaling
Interaction domains recognize exposed features of their binding partners containing post-translationally modified sequences,...
Interaction domains in cell signaling
Interaction domains recognize exposed features of their binding partners containing post-translationally modified sequences,...
5.7K
The Equilibrium Binding Constant and Binding Strength
12.9K
The equilibrium binding constant (Kb) quantifies the strength of a protein-ligand interaction. Kb can be calculated as follows when the reaction is at equilibrium:
12.9K
Protein Complexes with Interchangeable Parts
2.5K
Groups of proteins may form a complex where each protein in this complex has a different role in the overall execution of the complex’s function. Often some of the proteins in the complex can be replaced by a closely related variant to give a complex that contains many of the same components yet is functionally distinct.
The SCF ubiquitin ligase is a protein complex of five individual proteins. This complex attaches ubiquitin to other target proteins to mark them for degradation. In order...
The SCF ubiquitin ligase is a protein complex of five individual proteins. This complex attaches ubiquitin to other target proteins to mark them for degradation. In order...
2.5K


